NCT06289322 · NOT YET RECRUITING

AI4HOPE Pilot Study 1 Digital Toolkit Assessment

This pilot study is building and testing a standardized digital toolkit for assessing people who already have mild to moderate dementia. The goal is to find out whether it gives reliable information without being too tiring for patients. It is not a drug or treatment. Phase does not apply here. It is an early, small-scale test of a tool.

You may qualify if

  • Mild to moderate dementia of any type
  • Montrea Cognitive Assessment (MoCA) score of 16-25
  • Living at home, or in residential or nursing home care
  • Receiving adequate social support

You're excluded if

  • Moderate/severe cognitive impairment (MoCA \< 16)
  • No cognitive impairment (MoCA >25)
  • Inpatient or acute hospital treatment
  • Infectious diseases or lokal skin conditons preventing the use of wearable body sensors

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-05

View full record on ClinicalTrials.gov

All APOE4 clinical trials